PF-06439535

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-06439535, covering 2014-08-15 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC [Phase 3]

See pricing